Takeda Pharmaceutical
TAK
#489
Rank
S$61.40 B
Marketcap
S$18.45
Share price
0.28%
Change (1 day)
2.44%
Change (1 year)

Takeda Pharmaceutical (TAK) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : S$64.34 Billion

According to Takeda Pharmaceutical's latest financial reports the company's total liabilities are S$64.34 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Takeda Pharmaceutical - Total liabilities on balance sheet (from 2008 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-03-31S$65.51 B-6.05%
2024-03-31S$69.74 B-8.02%
2023-03-31S$75.82 B-9.04%
2022-03-31S$83.36 B-11.26%
2021-03-31S$93.94 B-12.23%
2020-03-31S$107.03 B1.93%
2019-03-31S$105.00 B307.55%
2018-03-31S$25.76 B-14.39%
2017-03-31S$30.09 B38.5%
2016-03-31S$21.73 B-9.13%
2015-03-31S$23.91 B-3.31%
2014-03-31S$24.73 B9.6%
2013-03-31S$22.56 B3.45%
2012-03-31S$21.81 B122.09%
2011-03-31S$9.82 B0.18%
2010-03-31S$9.80 B-9.84%
2009-03-31S$10.87 B53.12%
2008-03-31S$7.10 B-9.83%
2007-03-31S$7.87 B-17.83%
2006-03-31S$9.58 B14.39%
2005-03-31S$8.38 B-6.18%
2004-03-31S$8.93 B21.2%
2003-03-31S$7.37 B-2.38%
2002-03-31S$7.54 B5.83%
2001-03-31S$7.13 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
S$147.33 B 128.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$85.67 B 33.16%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
S$150.05 B 133.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$81.15 B 26.12%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Seagen
SGEN
S$1.40 B-97.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
S$2.62 B-95.92%๐Ÿ‡ฎ๐Ÿ‡ณ India
Amgen
AMGN
S$104.48 B 62.39%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$79.52 B 23.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
S$100.74 B 56.57%๐Ÿ‡บ๐Ÿ‡ธ USA